#180 Beta-Blockers & REDUCE-AMI Trial: Beyond...

Why can lower-dose combinations be more effective and better tolerated than maximizing one medication? How to troubleshoot common challenges such as amlodipine edema, gout, electrolyte abnormalities, and the patient who says they cannot tolerate anything? Why ACT (ARBs, Calcium C ...  Show more

Learn from primary care docs what has been practiced and changed from the 2026 ACC/AHA Lipid Guidelines! Learn how the new CPR framework (Calculate, Personalize, Reclassify) and PREVENT risk calculator change statin decisions, why LDL targets are back, and when to use Lp(a), ApoB ...  Show more

Beta-blockers post MI, public perception of statins, trust in the medical profession, BMI, and TAVI are the topics John Mandrola, MD, covers in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript ...

In this episode, Dr Matt and Dr Mike discus drugs that are used to treat cardiovascular diseases.

YouTube: https://www.youtube.com/@DrMattDrMike/

Email: gubiosciences ...

Beta-blockers are commonly used in the management of hypertension as well as rate control for atrial fibrillation. On this episode, I breakdown some of the most common agent and what to look out for. Enjoy the show! All subscribers to the website/podcast will get access to a FREE ...  Show more

AF screening, BNP, a new SGLT2 inhibitor, a sky-is-blue study, and the UK Mini Mitral surgical trial are discussed in this week's podcast

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit: